Innovating to improve health worldwide

We are the voice of the innovative pharmaceutical industry, collaborating for global health progress to improve lives everywhere.

Areas of work About us
A female lab technician examining the contents of a petri dish

Latest news

Statement 18 May 2026

79th World Health Assembly (WHA79): Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement

On 18 May 2026, IFPMA delivered a statement on the Open-Ended Intergovernmental Working Group on the WHO Pandemic Agreement at the 79th World Health Assembly in Geneva. The innovative pharmaceutical industry remains a critical partner in pandemic preparedness and response, with a strong track record of action during pandemics and Public Health Emergencies of International...

Read more
Statement 14 May 2026

Multi-Stakeholder Hearing for the 2026 UN High-Level Meeting on HIV/AIDS

On 14 May 2026 in New York City, IFPMA delivered a statement at the Multi-Stakeholder Hearing ahead of the UN High-Level Meeting on HIV/AIDS. The 2026 High-Level Meeting comes at a sensitive but important moment for the global HIV response. Meaningful progress has been made, but it remains fragile, uneven, and vulnerable to reversal if...

Read more
Statement 30 April 2026

Sixth resumed meeting of the open-ended Intergovernmental Working Group (IGWG 6) on the WHO Pandemic Agreement: PABS instrument

On 30 April 2026, IFPMA delivered a statement at the Sixth resumed meeting of the open-ended Intergovernmental Working Group (IGWG 6) on the WHO Pandemic Agreement.

Read more
Expert insights 29 April 2026

Foundations of competitiveness and growth start with strong healthcare systems and healthy populations

Earlier this month, the OECD released an important report on how to drive competitiveness and growth (F4GC), noting that we are at a time where economic prospects are under pressure due to short-term uncertainty and longer-term productivity challenges. While the report rightly emphasizes key drivers such as regulation, skills, and resource allocation, health is addressed...

Read more
Position paper 20 April 2026

Advancing GMP inspection reliance - from pilots to practice

Around the world, National Regulatory Agencies (NRAs) face mounting pressure to ensure access to and availability of high-quality medicinal products while confronted with an increasing number of sites to inspect, a demand driven by a need to strengthen supply resilience and manage limited inspection resources. This position paper represents the views of the research-based biopharmaceutical...

Read more
Statement
79th World Health Assembly (WHA79): Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement
Statement
Multi-Stakeholder Hearing for the 2026 UN High-Level Meeting on HIV/AIDS
Statement
Sixth resumed meeting of the open-ended Intergovernmental Working Group (IGWG 6) on the WHO Pandemic Agreement: PABS instrument
Expert insights
Foundations of competitiveness and growth start with strong healthcare systems and healthy populations
Position paper
Advancing GMP inspection reliance - from pilots to practice

Initiatives

See all

#AlwaysInnovating

Investing in innovative medicines and vaccines doesn’t just save lives – it transforms our future. It strengthens health, drives economic growth, and improves health security.

Read more

#VaccinesForLife

Investing in adult vaccination programmes can help protect lives, our healthcare systems, and our economies. Read the new report by the Office of Health Economics to discover more.

Read more

#AlwaysInnovating

#AlwaysInnovating lifts the curtain on the innovation journey, revealing the knowledge, skills, collaboration, and perseverance needed to turn an idea into a medicine or vaccine that brings hope to people everywhere.

Read more

Global Health Progress

Explore how the innovative pharmaceutical industry is collaborating across global health actors to support the Sustainable Development Goals in low- and middle-income countries.

Visit microsite
#VaccinesForLife skyscraper
#alwaysinnovating campaign image - an illustration of a microscope with a lightbulb
Global Health Progress campaign image - a group of children in front of the SDG wheel
A female lab technician looking through a microscope

Collaborating for global health progress

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents the innovative pharmaceutical industry at the international level and in official relations with the United Nations.

About us

Areas of work

See all
Lightbulb

Fostering a thriving health innovation ecosystem
Heart

Advancing sustainable health systems
Mask

Improving health security and pandemic preparedness
Document

Strengthening regulatory systems
Scales

Upholding ethics and business integrity
Africa

Supporting Africa’s health ecosystem  

Our members

Representing over 90 of the most forward-looking companies and associations in the world.

See all
Novartis logo
Takeda logo
Bristol Myers Squibb logo
Chugai logo
Amgen logo
Merck logo
Top